drugset / Trial / NCT07429032
The Effect of AMG 133 on Gastric Emptying
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective of the trial is to evaluate the effect of AMG 133 versus placebo on acetaminophen pharmacokinetics (PK), a marker for gastric emptying, in participants living with overweight or obesity.
Timeline
- Start
- 2025-04-17
- Primary completion
- 2025-11-26
- Completion
- 2025-11-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acetaminophen | Small molecule | — | Oral |
| Subject | Maridebart Cafraglutide | Unknown | — | Subcutaneous |